TB

Tukaram Baliramrao Kulkarni

Director Director DIN 06559788
DIN 06559788 First appointment Sep 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2015
Shareholding value •••• Premium profile

About Tukaram Baliramrao Kulkarni

Data last updated:

Tukaram Baliramrao Kulkarni was a Director at Apex Medichem Private Limited (2015–2021) and Director at Satellite Pharmaceuticals Private Limited (2018–2021). The companies operate in Pharma.

DIN 06559788
Primary Designation Director
Industry Pharma
First Appointment 07 Sep 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apex Medichem Private Limited U24230MH2005PTC152123
Director07 Sep 20152005₹30.17 Cr (FY 2022)Active
Director26 Sep 20181994₹1.74 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apex Medichem Private Limited
Satellite Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tukaram Baliramrao Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tukaram Baliramrao Kulkarni

Tukaram Baliramrao Kulkarni was first appointed on 07 Sep 2015 as Director at Apex Medichem Private Limited. The most recent appointment on record is 26 Sep 2018 at Satellite Pharmaceuticals Private Limited.

Tukaram Baliramrao Kulkarni held 2 earlier board appointments: Apex Medichem Private Limited (Director, 07 Sep 2015 to 09 Mar 2021); Satellite Pharmaceuticals Private Limited (Director, 26 Sep 2018 to 02 Jun 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available